Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, today announced the successful dosing of the first patients across multiple ...
A lot has changed about the cancer treatment methods over the past few years. Doctors are increasingly paying attention to personalized medicine. And targeted therapy is one of the breakthroughs in ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
Scientists at Pune's Agharkar Research Institute developed a nanomedicine targeting breast cancer cells by silencing key ...
A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
Cancer cells often survive treatment by fixing the DNA damage that therapy is meant to cause. Researchers found that UNI418 ...
10don MSN
Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits
In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results